title: Evaluation of CYP1A1 and CYP2B1/2 m-RNA induction in rat liver slices using the NanoString technology: a novel tool for drug discovery lead optimization.
abstract: Cytochrome P450 (CYP) induction in rodents and humans is considered a liability for new chemical entities (NCEs) in drug discovery. In particular, CYP1A1 and CYP2B1/2 have been associated with the induction of liver tumors in oncogenicity studies during safety evaluation studies of potential drugs. In our laboratory, real time PCR (Taqman) has been used to quantify the induction of rat hepatic CYP1A1 and CYP2B1/2 in precision -cut rat liver slices. A novel technology that does not require m-RNA isolation or RT-PCR, (developed by NanoString Technologies) has been investigated to quantify CYP1A1 and CYP2B1/2 induction in rat liver slices. Seventeen commercially available compounds were evaluated using both Taqman and NanoString technologies. Precision-cut rat liver slices were incubated with individual compounds for 24 hr at 37 degrees C in a humidified CO(2) incubator and CYP1A1 and CYP2B1/2 m-RNA were quantified. The results from the NanoString technology were similar to those of the Taqman(R) with a high degree of correlation for both CYP isoforms (r(2)>0.85). Therefore, NanoString provides an additional new technology to evaluate the induction of CYP1A1 and 2B1/2, as well as potentially other enzymes or transporters in rat liver slices.
authors.affiliation: Schering-Plough Research Institute, Kenilworth, New Jersey 07033, USA. Jairam.Palamanda@spcorp.com
authors.forename: Jairam R
authors.initials: JR
authors.lastname: Palamanda
authors.forename: Pramila
authors.initials: P
authors.lastname: Kumari
authors.forename: Nicholas
authors.initials: N
authors.lastname: Murgolo
authors.forename: Larry
authors.initials: L
authors.lastname: Benbow
authors.forename: Xinjie
authors.initials: X
authors.lastname: Lin
authors.forename: Amin A
authors.initials: AA
authors.lastname: Nomeir
mesh_terms: D000818:Animals; D001189:Aryl Hydrocarbon Hydroxylases / Q000096:biosynthesis* / Q000235:genetics; D019295:Computational Biology; D019363:Cytochrome P-450 CYP1A1 / Q000096:biosynthesis* / Q000235:genetics; D019362:Cytochrome P-450 CYP2B1 / Q000096:biosynthesis* / Q000235:genetics; D055808:Drug Discovery / Q000379:methods*; D004790:Enzyme Induction; D057166:High-Throughput Screening Assays; D008099:Liver / Q000187:drug effects* / Q000201:enzymology; D008297:Male; D036103:Nanotechnology; D016133:Polymerase Chain Reaction; D012333:RNA, Messenger / Q000096:biosynthesis*; D051381:Rats; D017207:Rats, Sprague-Dawley; D015203:Reproducibility of Results; D013250:Steroid Hydroxylases / Q000096:biosynthesis* / Q000235:genetics; D046509:Tissue Culture Techniques
chemical_list: D012333:RNA, Messenger; D013250:Steroid Hydroxylases; D001189:Aryl Hydrocarbon Hydroxylases; D019363:Cytochrome P-450 CYP1A1; D019362:Cytochrome P-450 CYP2B1; C025619:steroid 16-beta-hydroxylase